A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D 2 receptor antagonists in rats-Reference-Cited by-同舟云学术

A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D 2 receptor antagonists in rats

Published:2016-10 Issue: Volume:789 Page:202-214
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Taneja Amit,Vermeulen An,Huntjens Dymphy R.H.,Danhof Meindert,De Lange Elizabeth C.M.,Proost Johannes H.

Funder

Dutch Top Institute Pharma

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration;Bagli;J. Pharmacol. Exp. Ther.,1999

2. NONMEM’s User’s Guides;Beal,2009

3. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacol. Rev.,2011

4. What can we learn from rodents about prolactin in humans?;Ben-Jonathan;Endocr. Rev.,2008

5. R:A Language and Environment for Statistical Computing;Core Team,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a non-human primate model to support CNS translational research: Demonstration with D-amphetamine exposure and dopamine response;Journal of Neuroscience Methods;2019-04

2. Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D2 receptor activation using multi-biomarker pharmacokinetic/pharmacodynamic modelling;British Journal of Pharmacology;2018-08-31

3. Schizophrenia: synthetic strategies and recent advances in drug design;MedChemComm;2018

4. Modeling of prolactin response following dopamine D2 receptor antagonists in rats: can it be translated to clinical dosing?;Pharmacology Research & Perspectives;2017-11-21

5. Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling;The AAPS Journal;2016-10-26